Wednesday, July 8, 2026

Patent intelligence · US

US 7811297

Actuable structures and methods of fabrication and use

granted A61KA61K9/0009A61K9/0097
Status granted
Linked drugs 1
Pipeline programs 6
Years to expiry 4
Applicant portfolio 82
Patent details — US 7811297

Quick answer

US 7811297 (Actuable structures and methods of fabrication and use) is held by TELEDYNE SCIENTIFIC & IMAGING, LLC. Status: granted. Granted Oct 12, 2010. Expires Oct 7, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
13
CPC classes
A61K, A61K9/0009, A61K9/0097

More from TELEDYNE SCIENTIFIC & IMAGING, LLC

Related pharmaceutical patents in our USPTO index.

  1. US 12428487

    Complexes comprising an anti-transferrin receptor antibody linked to an oligonicleotide and method of delivering oligonucleotide to a subject

    Dyne Therapeutics, Inc. · Expires Sep 25, 2045

    granted
  2. US 12403203

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Expires Aug 28, 2045

    granted
  3. US 12397062

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Expires Aug 21, 2045

    granted
  4. US 12370264

    Complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of delivering oligonucleotide to a subject

    Dyne Therapeutics, Inc. · Expires Jul 24, 2045

    granted
  5. US 12357703

    Muscle-targeting complexes comprising an anti-transferin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping

    Dyne Therapeutics, Inc. · Expires Jul 10, 2045

    granted
  6. US 12329824

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Expires Jun 12, 2045

    granted
  7. US 12329825

    Muscle targeting complexes comprising an anti-transferrin receptor antibody linked to an oligonucleotide and method of use thereof to induce exon skipping of exon 44 of dystrophin in a subject

    Dyne Therapeutics, Inc. · Expires Jun 12, 2045

    granted
  8. US 12325753

    Method of using an anti-transferrin receptor antibody to deliver an oligonucleotide to a subject having facioscapulohumeral muscular dystrophy

    Dyne Therapeutics, Inc. · Expires Jun 5, 2045

    granted

Frequently asked questions

What is US patent 7811297?

US 7811297 (Actuable structures and methods of fabrication and use) is held by TELEDYNE SCIENTIFIC & IMAGING, LLC. Status: granted. Granted Oct 12, 2010. Expires Oct 7, 2030 (4 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 7811297?

TELEDYNE SCIENTIFIC & IMAGING, LLC is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 82 pharmaceutical patents for this assignee.

When does US 7811297 expire?

Our index shows an expiration date of Oct 7, 2030 (4 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.